Manon Gauthier

Manon Gauthier  


Executive Summary

Manon Gauthier is a partner in our business and commercial group. Her practice is focused on mergers and acquisitions, company law, venture capital and life sciences.

Manon acts as lead lawyer in mergers and sales of private companies, working in sectors as varied as biotechnology, the pharmaceutical industry, telecommunications, information technology, energy, transportation and engineering. She also acts for investment funds or private companies in venture capital financing.

Manon also acts as counsel for companies operating in the sectors of pharmaceuticals, biologics, medical devices and life sciences with respect to corporation agreements, homologation, manufacture, design, clinical testing, advertising, supply, distribution and sale of pharmaceuticals, medical devices, cosmetics and other health-related products and technologies. She also advises pharmaceutical companies in their interaction with health professionals and health care establishments.

Representative Work

  • Participated in several sales and purchase of businesses, including, most recently, the sale of shares of a probiotic products manufacturer and those of a manufacturer of anodised doors and window frames, to Québec-based investment funds.
  • Acted for venture capital funds, including BDC Capital Inc. and the Fonds de solidarité des travailleurs du Québec (FTQ) in several venture capital transactions.
  • Participated in establishing investment funds.
  • Assisted Bell Canada in the acquisition of Le Groupe Créatech.
  • Assisted Bell Canada and the managers of the Bell Nordiq Income Fund with the Fund's $326-million initial public offering.
  • Assisted several pharmaceutical companies in major commercial projects involving health professionals.
  • Involved in developing the corporate structure of and concluding commercial agreements relating to hydroelectric and wind farm projects.

Publications & Presentations

  • Speaker at various conferences for business lawyers and BLG colleagues on subjects such as mergers and acquisitions, due diligence related to operations, and pharmaceutical law.

Rankings & Recognitions

  • Recognized in the 2017, 2016 and 2015 editions of The Canadian Legal Lexpert® Directory (Private Equity).
  • Recognized in the 2012 edition of PLC Which lawyer (Life Sciences: Corporate and Commercial law).